July 8, 2025 – By Grow Opportunity
July 8, 2025, Dublin, Ireland — The Canada Legal Cannabis Market, Region, Competition, Forecast & Opportunities, 2020-2030F report, which was recently added to ResearchAndMarkets.com’s offering, is expected to reach $7.19 billion USD by 2030, up from a valuation of $3.61 billion USD in 2024.
A key market driver of this growth is the rising medical cannabis adoption, led by public awareness around its therapeutic benefits, especially for chronic pain, insomnia, anxiety, and neurological conditions.
Daily medical cannabis usage reportedly rose from 83.2 per cent pre-pandemic to 90.3 per cent during the pandemic, stated a 2021 patient survey cited in a press release.
Surveys also highlight higher usage among Indigenous populations compared to non-Indigenous groups, signalling varied adoption across demographics.
Insurance support and innovations tailored to specific health needs are expected to further accelerate growth in the medical cannabis segment, reinforcing its contribution to the overall market expansion.
A challenge highlighted in the report is the complex and inconsistent provincial regulations, which complicate logistics and supply chain planning for multi-region operators and hinder market expansion efforts.
Additionally, regulatory fragmentation inflates compliance costs, discourages new entrants and creates uncertainty for investors.
Key market trends identified in the report include the expansion of cannabis 2.0 and 3.0 products.
Cannabis 2.0, introduced in 2019, brought edibles, beverages, vapes, and topicals to market, offering alternatives to traditional smoking.
These formats appeal to health-conscious consumers seeking discreet, low-dose or controlled experiences. Cannabis-infused beverages, in particular, have gained popularity for their convenience and social appeal.
The next wave, Cannabis 3.0, includes advanced delivery systems, personalized formulations and wellness-focused applications such as cannabis-infused skincare and nutraceuticals, the company reported in a media statement.
These products often leverage precise dosing and enhanced bioavailability technologies like nanoemulsion, appealing to both new and experienced users.
The key market players in the Canadian cannabis market were identified as:
- Canopy Growth Corporation
- Charlotte’s Web, Inc.
- Aurora Cannabis Inc.
- Tilray Brands
- The Cronos Group
- Jazz Pharmaceuticals, Inc.
- Organigram Holding, Inc.
- Maricann, Inc.
- Isodiol International, Inc
- Sundial Growers
For more information about this report visit https://www.researchandmarkets.com/r/6hidne.
View other cannabis industry news – Click Here